多发性单神经炎

Burns TM, Schaublin GA, Dyck PJ. Vasculitic neuropathies. Neurol Clin. 2007;25:89-113.

• 摘要

Rudnicki SA, Dalmau J. Paraneoplastic syndromes of the peripheral nerves. Curr Opin Neurol. 2005;18:598-603.

• 摘要

1.  Collins MP, Kissel JT. Neuropathies with systemic vasculitis. In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy. 4th ed. Vol. 2. Philadelphia, PA: Elsevier Saunders; 2005:2335-2404.

2.  Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum. 1994;37:187-192.

• 摘要

3.  Chia L, Fernandez A, Lacroix C, et al. Contribution of nerve biopsy findings to the diagnosis of disabling neuropathy in the elderly: a retrospective review of 100 consecutive patients. Brain. 1996;119:1091-1098.

• 全文
• 摘要

4.  Said G, Lacroix-Ciaudo C, Fujimura H, et al. The peripheral neuropathy of necrotizing arteritis: a clinicopathological study. Ann Neurol. 1988;23:461-465.

• 摘要

5.  Hawke SH, Davies L, Pamphlett R, et al. Vasculitic neuropathy: a clinical and pathological study. Brain. 1991;114:2175-2190.

• 摘要

6.  Langford CA. Vasculitis. J Allergy Clin Immunol. 2003;111(2 Suppl):S602-S612.

• 摘要

7.  Kamesh L, Harper L, Savage CO. ANCA-positive vasculitis. J Am Soc Nephrol. 2002;13:1953-1960.

• 全文
• 摘要

8.  Dyck PJ, Benstead TJ, Conn, DL, et al. Nonsystemic vasculitic neuropathy. Brain. 1987;110:843-853.

• 摘要

9.  Stone JH. Polyarteritis nodosa. JAMA. 2002;288:1632-1639.

• 摘要

10.  Cattaneo L, Chierici E, Pavone L, et al. Peripheral neuropathy in Wegener's granulomatosis, Churg-Strauss syndrome and microscopic polyangiitis. J Neurol Neurosurg Psychiatr. 2007;78:1119-1123.

• 摘要

11.  Nishino H, Rubino FA, DeRemee RA, et al. Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol. 1993;33:4-9.

• 摘要

12.  Delalande S, de Seze J, Fauchais AL, et al. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore). 2004;83:280-291.

• 摘要

13.  Ramos-Casals M, Nardi N, Lagrutta M, et al. Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients. Medicine (Baltimore). 2006;85:95-104.

• 摘要

14.  Genta MS, Genta RM, Gabay C. Systemic rheumatoid vasculitis: a review. Semin Arthritis Rheum. 2006;36:88-98.

• 摘要

15.  Vollertsen RS, Conn DL, Ballard DJ, et al. Rheumatoid vasculitis: survival and associated risk factors. Medicine (Baltimore). 1986;65:365-375.

• 摘要

16.  Burns TM. Vasculitic neuropathy. Continuum. 2003;9:146-159.

17.  Chapelon C, Ziza JM, Piette JC, et al. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine (Baltimore). 1990;69:261-276.

• 摘要

18.  Golbus J, McCune WJ. Giant cell arteritis and peripheral neuropathy: a report of 2 cases and review of the literature. J Rheumatol. 1987;14:129-134.

• 摘要

19.  Chan WM, Liu DT, Chan AY, et al. ANCA-associated giant cell arteritis presenting with mononeuritis multiplex and central retinal artery occlusion: a case report. Rheumatology (Oxford). 2004;43:529-531.

• 摘要

20.  Campbell SB, Hawley CM, Staples C. Mononeuritis multiplex complicating Henoch-Schonlein purpura. Aust N Z J Med. 1994;24:580.

• 摘要

21.  Griffin JW. Vasculitic neuropathies. Rheum Dis Clin North Am. 2001;27:751-760.

• 摘要

22.  Olney RK. AAEM minimonograph #38: neuropathies in connective tissue disease. Muscle Nerve. 1992;15:531-542.

• 摘要

23.  Said G, Lacroix C. Primary and secondary vasculitic neuropathy. J Neurol. 2005;252:633-641.

• 摘要

24.  Moore PM. Immune mechanisms in the primary and secondary vasculitides. J Neurol Sci. 1989;93:129-145.

• 摘要

25.  Griem P, Wulferink M, Sachs B, et al. Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunol Today. 1998;19:133-141.

• 摘要

26.  Said G. Necrotizing peripheral nerve vasculitis. Neurol Clin. 1997;15:835-848.

• 摘要

27.  Delaney P. Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med. 1977;87:336-345.

• 摘要

28.  Cacoub P, Maisonobe T, Thibault V, et al. Systemic vasculitis in patients with hepatitis C. J Rheumatol. 2001;28:109-118.

• 摘要

29.  Burns TM, Schaublin GA, Dyck PJ. Vasculitic neuropathies. Neurol Clin. 2007;25:89-113.

• 摘要

30.  Ten Holder SM, Joy MS, Falk RJ, et al. Cutaneous and systemic manifestations of drug-induced vasculitis. Ann Pharmacother. 2002;36:130-147.

• 摘要

31.  Birnbaum J. Infliximab-associated neuropathy in RA patients - the importance of considering the diagnosis of mononeuritis multiplex. Clin Rheumatol. 2007;26:281-282.

• 摘要

32.  Mauermann ML, Ryan ML, Moon JS, et al. Case of mononeuritis multiplex onset with rituximab therapy for Waldenstrom's macroglobulinemia. J Neurol Sci. 2007;260:240-243.

• 摘要

33.  World Health Organization. Leprosy prevalence rates: data reported to WHO as of January 2012. http://www.who.int/ (last accessed 28 July 2017).

• 全文

34.  Garg S, Wright A, Reichwein R, et al. Mononeuritis multiplex secondary to sarcoidosis. Clin Neurol Neurosurg. 2005;107:140-143.

• 摘要

35.  Said G. Lyme disease. In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy. 4th ed. Vol. 2. Philadelphia, PA: Elsevier Saunders; 2005:2109-2116.

36.  Vincent D, Gombert B, Vital A, et al. A case of mononeuropathy multiplex with type II cryoglobulinemia, necrotizing vasculitis and low grade B cell lymphoma. Clin Neuropathol. 2007;26:28-31.

• 摘要

37.  Monti G, Galli M, Invernizzi F, et al. Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias. QJM. 1995;88:115-126.

• 摘要

38.  Hagen EC, Daha MR, Hermans J, et al; EC/BCR Project for ANCA Assay Standardization. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney Int. 1998;53:743-753.

• 全文
• 摘要

39.  Noth I, Strek ME, Leff AR. Churg-Strauss syndrome. Lancet. 2003;361:587-594.

• 摘要

40.  Said G, Lacroix C. Sarcoid neuropathy. In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy. 4th ed. Vol. 2. Philadelphia, PA: Elsevier Saunders; 2005:2415-2425.

41.  Collins MP, Mendell JR, Periquet MI, et al. Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy. Neurology. 2000;55:636-643.

• 摘要

42.  Vital C, Vital A, Canron MH, et al. Combined nerve and muscle biopsy in the diagnosis of vasculitic neuropathy. A 16-year retrospective study of 202 cases. J Peripher Nerv Syst. 2006;11:20-29.

• 摘要

43.  Kawakami T, Soma Y, Kawasaki K, et al. Initial cutaneous manifestations consistent with mononeuropathy multiplex in Churg-Strauss syndrome. Arch Dermatol. 2005;141:873-878.

• 摘要

44.  Lee JE, Shun CT, Hsieh SC, et al. Skin denervation in vasculitic neuropathy. Arch Neurol. 2005;62:1570-1573.

• 全文
• 摘要

45.  Sabin TD, Swift TR, Jacobson RR. Leprosy. In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy. 4th ed. Vol. 2. Philadelphia, PA: Elsevier Saunders; 2005:2081-2108.

46.  Harrison TR, Fauci AS, Braunwald E, et al. Harrison's principles of internal medicine. 14th ed. Vol 2. New York, NY: McGraw-Hill; 1997:1874-1928.

47.  Stanson AW, Friese JL, Johnson CM, et al. Polyarteritis nodosa; spectrum of angiographic findings. Radiographics. 2001;21:151-159.

• 全文
• 摘要

48.  Vrancken AF, Hughes RA, Said G, et al. Immunosuppressive treatment for non-systemic vasculitic neuropathy. Cochrane Database Syst Rev. 2007;(1):CD006050.

• 全文
• 摘要

49.  Lau JY, Bird GL, Alexander GJ, et al. Effects of immunosuppressive therapy on hepatic expression of hepatitis B viral genome and gene products. Clin Invest Med. 1993;16:226-236.

• 摘要

50.  Guillevin L, Cohen P, Larroche C, et al. Treatment of HBV-related polyarteritis nodosa with lamivudine and plasma exchanges: a prospective, multicenter, pilot trial in 10 patients. Annual Scientific Meeting, San Francisco, 2001; abstract 1311. Arthritis Rheum. 2001;44(Suppl 9):S271.

• 全文

51.  Gupta S, Piraka C, Jaffe M. Lamivudine in the treatment of polyarteritis nodosa associated with acute hepatitis B. N Engl J Med. 2001;344:1645-1646.

• 摘要

52.  Boonyapisit K, Katirji B. Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review. Muscle Nerve. 2002;25:909-913.

• 摘要

53.  American Association for the Study of Liver Diseases. HCV guidance: recommendations for testing, managing, and treating hepatitis C. February 2016. http://hcvguidelines.org/ (last accessed 28 July 2017).

• 全文

54.  Verma, A. Epidemiology and clinical features of HIV-1 associated neuropathies. J Peripher Nerv Syst. 2001;6:8-13.

• 摘要

55.  Rudnicki SA, Dalmau J. Paraneoplastic syndromes of the peripheral nerves. Curr Opin Neurol. 2005;18:598-603.

• 摘要

56.  Scott TF, Stern BJ. Treatment of neurosarcoidosis. In: Noseworthy JH, ed. Neurological therapeutics principles and practice. 2nd ed. Vol. 2. London: Informa Healthcare Books; 2006:1602-1607.

57.  Molloy ES, Langford CA. Advances in the treatment of small vessel vasculitis. Rheum Dis Clin North Am. 2006;32:157-172.

• 摘要

58.  Schmitt WH, Hagen EC, Neumann I, et al. Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients. Kidney Int. 2004;65:1440-1448.

• 摘要

59.  Judson MA, Baughman RP, Costabel U, et al. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomized trial. Eur Respir J. 2008;31:1189-1196.

• 摘要

60.  Aksamit A. Neurosarcoidosis. Continuum. 2008;14:181-196.

61.  Chan TM, Tse KC, Tang CS, et al. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis. J Am Soc Nephrol. 2005;16:1076-1084.

• 全文
• 摘要

62.  Hu W, Liu C, Xie H, et al. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement. Nephrol Dial Transplant. 2008;23:1307-1312.

• 摘要

63.  Collins MP, Periquet MI, Mendell JR, et al. Nonsystemic vasculitic neuropathy: insights from a clinical cohort. Neurology. 2003;61:623-630.

• 摘要